newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics Announces Appointment of Matthew Trudeau as Chief Commercial Officer

CCO appointment positions VBL to advance and accelerate commercialization strategy for ofra-vec (VB-111) Enrollment in the OVAL Study, a 400 patient Phase 3 registration-enabling trial in ovarian cancer, expected to be completed this quarter; P